Artesunate 50mg Injection Vials from Japan
Lyophilized artesunate 60mg (as 50mg base) powder for injection, artemisinin derivative antimalarial of note 2, for severe malaria IV use. Single-dose vials for retail/therapeutic under HTS 3004.60.00.00. Reconstituted with sodium bicarbonate.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Maintain 2-8°C cold chain; include reconstitution instructions
• Pitfall: stability post-reconstitution undocumented
• FDA requires ANDA for generics